Emergent Biosolutions (EBS) Files $180M Mixed Shelf; 3M Common for Shareholders
Tweet Send to a FriendGet Alerts EBS Hot Sheet
Up)
Trade EBS Now!
Emergent Biosolutions, Inc. (NYSE: EBS) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $180 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Emergent also filed to sell up to 3 million of its Common on behalf of selling shareholders. Emergent will not receive proceeds from the secondary offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Mayor Virg Bernero Leads Ribbon Cutting of Emergent BioSolutions’ New Administration Building Representing Another Step in Its Lansing Campus Expansion
- Opexa Therapeutics (OPXA) Files $17.25M Common Shelf
- Vitesse Semi (VTSS) Announces $30M Common Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
